Company Financials

Dallah Healthcare Company Financials

Saudi riyal

business Dallah Healthcare Company Company Profile

Main Stock Listing

Tadawul: 4004

Market Capitalization SR12.67 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 23.27
Forward PE 24.45
Price to Sales TTM SR3.36
Price to Book MRQ SR3.00
Enterprise to Revenue 4.30
Enterprise to EBITDA 21.02

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 14.23%
Operating Margin 14.85%
Return on Assets TTM 4.88%
Return on Equity TTM 12.94%

Income Statement

Revenue TTM SR3,765,209,088
Revenue per Share TTM SR37.90
Quarterly Revenue Growth 25.20%
Gross Profit TTM SR1,272,599,424
EBITDA SR846,100,668
Net Income to Common TTM SR535,626,272
Diluted EPS TTM SR5.38
Quarterly Earnings Growth YoY 12.50%

Balance Sheet

Total Cash MRQ SR153,665,392
Total Cash per Share MRQ SR1.52
Total Debt MRQ SR
Total Debt to Equity MRQ 74.42
Current Ratio MRQ 1.28
Book Value per Share MRQ SR41.76

Cash Flow

Operating Cash Flow TTM SR526,251,264
Levered Free Cash Flow TTM SR-232,599,632

4004 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 101,197,219
Float Shares 44,177,646
Avg 10 Volume 62,558
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 56.26%
% Held by Institutions 4.43%

Stock Price Summary

Beta 0.07
Fifty Two Week Low SR109.00
Fifty Two Week High SR161.20
Fifty Two Week Change -22.68%
Day 50 MA SR135.69
Day 200 MA SR130.80

Dividends and Splits

Forward Annual Dividend Rate SR2.00
Forward Annual Dividend Yield 1.60%
Trailing Annual Dividend Rate SR2.00
Trailing Annual Dividend Yield 1.60%
Payout Ratio 37.11%
Dividend Date
Ex Dividend Date 2025-11-11
Last Split Factor
Last Split Date 2020-09-14